FiBAN Case Hearing: Painoklinikka (Online)
Painoklinikka is building WeightPilot, a digital platform designed to make personalised obesity care scalable. As GLP-1 medicines transform obesity treatment, the company is developing the care around them: practical support for nutrition, daily habits and ongoing follow-up, connected to healthcare professionals.
WeightPilot builds on an operating Finnish obesity-care business:
€250,000 in revenue in 2025, more than 2,500 patients served to date and six B2B customers.
A nationwide remote clinic combining medical care, nutrition, psychology and nursing support.
Paid pharmaceutical-sector assignments, including expert services and WeightPilot-related digital-care development.
A live MVP being tested in three languages with patients and partners across international markets.
A multidisciplinary team spanning obesity medicine, research, nutrition, digital health and commercial operations.
The planned recurring revenue model combines patient subscriptions with licences and per-active-patient fees for care providers and employers. Initial commercial development will focus on Finland through Painoklinikka’s own patient channel, followed by partner-led international expansion once paying demand and engagement have been validated.
Painoklinikka is raising €600,000 in equity at a €3.0 million pre-money valuation to fund WeightPilot’s commercial release, staged clinical validation and regulatory preparation, and commercial development. The investment opportunity is to help an established clinical business develop into a scalable digital-care platform.
Join us online to hear from the founder, lead investors ask your questions and get the answers. No strings attached. If you find your next investment case here, great! If not, on to the next one!
Agenda:
Intro by founders (5-10min)
Latest progress from company (5-10min)
Lead/committed investor comments (3min)
Q&A (20-30min)
This is a FiBAN investor event, outside participants allowed with strong referrals.